{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:10:25Z","timestamp":1790831425795,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.nmd.2017.04.002","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T17:48:21Z","timestamp":1491414501000},"page":"650-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["HLA and age of onset in myasthenia gravis"],"prefix":"10.1016","volume":"27","author":[{"given":"Ernestina","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia","family":"Bettencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Martins","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Boleixa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Br\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Pinho e","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta Martins","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nmd.2017.04.002_bib0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis","volume":"103","author":"Compston","year":"1980","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.nmd.2017.04.002_bib0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis \u2013 autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2017.04.002_bib0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1468-1331.2012.03850.x","article-title":"Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996\u20132009","volume":"20","author":"Pedersen","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2017.04.002_bib0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/ane.12233","article-title":"Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries","volume":"198","author":"Andersen","year":"2014","journal-title":"Acta Neurol Scand Suppl"},{"issue":"12","key":"10.1016\/j.nmd.2017.04.002_bib0030","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1468-1331.2010.03089.x","article-title":"Myasthenia gravis requiring pyridostigmine treatment in a national population cohort","volume":"17","author":"Andersen","year":"2010","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2017.04.002_bib0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1212\/WNL.0b013e3181ad53c2","article-title":"Seropositive myasthenia gravis: a nationwide epidemiologic study","volume":"73","author":"Heldal","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2017.04.002_bib0040","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000328863","article-title":"Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years","volume":"36","author":"Pallaver","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"9","key":"10.1016\/j.nmd.2017.04.002_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106757","article-title":"Insights into the classification of myasthenia gravis","volume":"9","author":"Akaishi","year":"2014","journal-title":"PLoS ONE"},{"issue":"5\u20136","key":"10.1016\/j.nmd.2017.04.002_bib0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02115001","article-title":"Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis","volume":"31","author":"Carlsson","year":"1990","journal-title":"Immunogenetics"},{"issue":"5","key":"10.1016\/j.nmd.2017.04.002_bib0055","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/joim.12310","article-title":"The autoimmune spectrum of myasthenia gravis: a Swedish population-based study","volume":"277","author":"Fang","year":"2015","journal-title":"J Intern Med"},{"issue":"4","key":"10.1016\/j.nmd.2017.04.002_bib0060","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/jamaneurol.2014.4493","article-title":"New insights into the genetics of autoimmune myasthenia gravis: an evolving story","volume":"72","author":"Lisak","year":"2015","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2017.04.002_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036603","article-title":"Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population","volume":"7","author":"Maniaol","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2017.04.002_bib0070","article-title":"Association of HLA-DQB1 *05:02 and DRB1 *16 alleles with late-onset, nonthymomatous, AChR-Ab-positive myasthenia gravis","volume":"2012","author":"Testi","year":"2012","journal-title":"Autoimmune Dis"},{"issue":"3","key":"10.1016\/j.nmd.2017.04.002_bib0075","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.410210309","article-title":"Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types","volume":"21","author":"Kida","year":"1987","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2017.04.002_bib0080","first-page":"255","article-title":"Clinical characteristics of refractory myasthenia gravis patients","volume":"86","author":"Suh","year":"2013","journal-title":"Yale J Biol Med"},{"issue":"4\u20135","key":"10.1016\/j.nmd.2017.04.002_bib0085","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.autrev.2014.01.049","article-title":"The diagnosis and clinical significance of polyautoimmunity","volume":"13","author":"Anaya","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.nmd.2017.04.002_bib0090","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.nmd.2017.04.002_bib0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-0039.1992.tb01940.x","article-title":"HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation","volume":"39","author":"Olerup","year":"1992","journal-title":"Tissue Antigens"},{"issue":"3","key":"10.1016\/j.nmd.2017.04.002_bib0100","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/jnnp.71.3.352","article-title":"Epidemiology of seropositive myasthenia gravis in Greece","volume":"71","author":"Poulas","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.nmd.2017.04.002_bib0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.65.4.492","article-title":"Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England","volume":"65","author":"Robertson","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.nmd.2017.04.002_bib0110","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1212\/01.WNL.0000050461.05432.C5","article-title":"Myasthenia gravis: a higher than expected incidence in the elderly","volume":"60","author":"Aragon\u00e8s","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nmd.2017.04.002_bib0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000336002","article-title":"Epidemiology and geographical variation of myasthenia gravis in the province of Pavia, Italy","volume":"38","author":"Montomoli","year":"2012","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.nmd.2017.04.002_bib0120","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1023\/A:1007449221638","article-title":"Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy","volume":"14","author":"Guidetti","year":"1998","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"10.1016\/j.nmd.2017.04.002_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nrl.2014.09.007","article-title":"Prevalence of myasthenia gravis in the Catalan county of Osona","volume":"32","author":"Aragon\u00e8s","year":"2014","journal-title":"Neurologia"},{"issue":"9","key":"10.1016\/j.nmd.2017.04.002_bib0130","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.57.9.1555","article-title":"Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies","volume":"57","author":"Giraud","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nmd.2017.04.002_bib0135","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ana.23691","article-title":"Risk for myasthenia gravis maps to a (151) Pro\u2192Ala change in TNIP1 and to human leukocyte antigen-B*08","volume":"72","author":"Gregersen","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2017.04.002_bib0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clim.2016.05.003","article-title":"Alahgholi-Hajibehzad M. Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis","volume":"166\u2013167","author":"Saruhan-Direskeneli","year":"2016","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.nmd.2017.04.002_bib0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clineuro.2012.04.001","article-title":"Association of HLA-DR\/DQ polymorphism with myasthenia gravis in Tunisian patients","volume":"115","author":"Fekih-Mrissa","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"10.1016\/j.nmd.2017.04.002_bib0150","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1468-1331.2003.00686.x","article-title":"HLA class II genotypes in Mexican Mestizo patients with myasthenia gravis","volume":"10","author":"Garc\u00eda-Ramos","year":"2003","journal-title":"Eur J Neurol"},{"issue":"1\u20132","key":"10.1016\/j.nmd.2017.04.002_bib0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2011.08.023","article-title":"The association of HLA-DQA1*0401 and DQB1*0604 with thymomatous myasthenia gravis in northern Chinese patients","volume":"312","author":"Yang","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2017.04.002_bib0160","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/948723","article-title":"The Protective Role of HLA-DRB1(*)13 in autoimmune diseases","volume":"2015","author":"Bettencourt","year":"2015","journal-title":"J Immunol Res"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896617300603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896617300603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:04:45Z","timestamp":1760774685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896617300603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0960896617300603"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2017.04.002","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA and age of onset in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2017.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}